Search

Hims & Hers Health Inc

Затворен

СекторДефанзивни потребителски стоки

27.98 0.32

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

27.65

Максимум

28.75

Ключови измерители

By Trading Economics

Приходи

5.8M

-86M

Продажби

145M

753M

P/E

Средно за сектора

57.137

29.484

EPS

-0.1

Марж на печалбата

-11.456

Служители

2,442

EBITDA

16M

-63M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+17.21% upside

Дивиденти

By Acuity

Следващи печалби

2.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-412M

6.7B

Предишно отваряне

27.66

Предишно затваряне

27.98

Настроения в новините

By Acuity

50%

50%

44 / 130 Класиране в Consumer defensive

Hims & Hers Health Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.09.2026 г., 19:26 ч. UTC

News

Hims & Hers Health Inc faces legal challenges from the FTC and securities lawsuits, contributing to a modest decline in shares today while raising full-year 2026 guidance.

15.09.2026 г., 20:08 ч. UTC

News

Hims & Hers Health Inc faces a class action lawsuit over alleged misleading practices, contributing to a decline in shares during today's session.

14.09.2026 г., 23:06 ч. UTC

Hims & Hers Health Inc shares are higher in after-market hours, reflecting a modest gain since Monday's close. The stock remains below its 20-day moving average.

11.09.2026 г., 20:08 ч. UTC

News

JPMorgan initiates coverage with Neutral rating, $32 target.

10.09.2026 г., 20:08 ч. UTC

News

Hims & Hers Health Inc. shares are lower amid an ongoing investigation and a lawsuit from the Federal Trade Commission over customer data practices.

9.09.2026 г., 20:07 ч. UTC

News

Hims & Hers Health Inc. is under investigation for sharing customer data, contributing to a decline in shares, which are near the lower end of their one-month range.

1.09.2026 г., 19:16 ч. UTC

News

Hims & Hers Health Inc shares are trading lower amid an investigation into potential claims related to customer data practices following a Federal Trade Commission lawsuit.

31.08.2026 г., 23:06 ч. UTC

Social Media

Hims & Hers Health Inc expands services to Australia, enhancing men's health care options. Shares are trading higher in after-market hours following the announcement.

28.08.2026 г., 20:03 ч. UTC

News

Hims & Hers Health is under investigation amid regulatory scrutiny and negative press, contributing to a decline in shares today, continuing a downward trend since Thursday.

27.08.2026 г., 23:02 ч. UTC

Hims & Hers Health Inc shares are higher in after-market hours, maintaining a position above the 20-day moving average despite earlier session fluctuations.

26.08.2026 г., 23:06 ч. UTC

Hims & Hers Health Inc. is trading higher in after-market hours, rebounding from a session low and showing resilience since Wednesday's close.

25.08.2026 г., 19:16 ч. UTC

News

Hims & Hers Health gains despite scrutiny over Visa monitoring and potential $75,000 penalty related to weight-loss subscription service. Shares higher since Monday's close.

24.08.2026 г., 20:02 ч. UTC

News

Hims & Hers Health Inc faces operational challenges amid scrutiny from Visa and a lawsuit, contributing to a decline in stock price during today's session.

21.08.2026 г., 20:07 ч. UTC

News

Barclays maintains an Overweight rating on Hims & Hers Health, lowering its price target to $35. Shares are trading higher amid positive market sentiment.

20.08.2026 г., 23:11 ч. UTC

Hims & Hers Health shares are lower in after-market hours, with no specific news identified. The broader market sees mixed sentiment amid rising U.S. Treasury yields.

19.08.2026 г., 23:06 ч. UTC

Social Media
News

Hims & Hers Health Inc. shares are lower in after-market trading following a lawsuit from the FTC alleging deceptive practices regarding user privacy and billing.

18.08.2026 г., 19:36 ч. UTC

News

Hims & Hers Health Inc shares are declining amid an investigation into potential corporate wrongdoing and ongoing legal challenges involving CEO Andrew Dudum.

13.08.2026 г., 20:07 ч. UTC

News

Hims & Hers Health Inc shares are lower amid an investigation into potential corporate wrongdoing related to a Federal Trade Commission lawsuit.

12.08.2026 г., 19:41 ч. UTC

News
Social Media

Hims & Hers Health Inc. faces scrutiny over cautious peptide outlook and ongoing investigations into customer data sharing, contributing to a decline in shares today.

11.08.2026 г., 19:51 ч. UTC

News

Hims & Hers Health Inc shares are lower amid broader sector declines following a mixed earnings report and concerns over execution risks.

10.08.2026 г., 23:41 ч. UTC

News
Social Media

Hims & Hers Health reported a net loss of $86.3 million in Q2, contributing to a decline in share price during after-market trading.

7.08.2026 г., 19:26 ч. UTC

Hims & Hers Health Inc. shares are trading higher, reflecting strong intraday momentum, despite a slight pullback from earlier session highs amid falling Treasury yields.

6.08.2026 г., 19:16 ч. UTC

Social Media
News

Hims & Hers Health is under investigation amid ongoing legal scrutiny. Shares are lower today despite a significant investment and the launch of the Hers App.

4.08.2026 г., 19:22 ч. UTC

News
Social Media

Hims & Hers Health is higher as an investigation into potential claims is announced, following a lawsuit over customer medical information sharing.

3.08.2026 г., 23:41 ч. UTC

News

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

31.07.2026 г., 19:36 ч. UTC

Social Media
News

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

30.07.2026 г., 20:11 ч. UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

29.07.2026 г., 23:16 ч. UTC

Social Media
News

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

28.07.2026 г., 23:41 ч. UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

27.07.2026 г., 20:03 ч. UTC

News
Social Media

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

Сравнение с други в отрасъла

Ценова промяна

Hims & Hers Health Inc Прогноза

Ценова цел

By TipRanks

17.21% нагоре

12-месечна прогноза

Среден 32.818 USD  17.21%

Висок 42 USD

Нисък 26 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за Hims & Hers Health Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

14 ratings

3

Купи

11

Задържане

0

Продай

Настроение

By Acuity

44 / 130 Класиране в Дефанзивни потребителски стоки

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Hims & Hers Health Inc

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.